Publicações

Dypd Genotyping to Predict Toxicity in Patients with Stage Iii Colon Cancer Treated with 5-Fluorouracil-Based Adjuvant Chemotherapy in the Petacc-8 Phase Iii Trial

AuthID
P-00G-EVS

Author(s)

Boige, V

Vincent, M

Alexandre, P

Stoehlmacher, J

Tejpar, S

Landolfi, S

Le Malicot, K

Greil, R

Cuyle, PJAR

Yilmaz, MKN

Faroux, R

Matzdorff, A

Salazar, R

Sanches, E

Mineur, L

Lepage, C

Taieb, J

Laurent Puig, P

Tipo de Documento

Abstract

Year published

2015

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 33, Número: 15

Conference

Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 29-JUN 02, 2015, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000358036900803

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Dypd Genotyping to Predict Toxicity in Patients with Stage Iii Colon Cancer Treated with 5-Fluorouracil-Based Adjuvant Chemotherapy in the Petacc-8 Phase Iii Trial

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Dypd Genotyping to Predict Toxicity in Patients with Stage Iii Colon Cancer Treated with 5-Fluorouracil-Based Adjuvant Chemotherapy in the Petacc-8 Phase Iii Trial

Links Úteis

Ajuda